These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37747290)

  • 21. Incidence and predictors of vascular complications following transcatheter aortic valve implantation: A comparison of the MANTA and suture-based vascular closure devices.
    Sehgal K; Butala AD; Stub D; Palmer S; Noaman S; Haji K; Htun N; Johnston R; Walton A; Nanayakkara S
    Catheter Cardiovasc Interv; 2024 Oct; 104(4):812-819. PubMed ID: 39138822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Outcomes After Percutaneous Closure of Access Site in Transfemoral Transcatheter Valve Implantation Using the Novel Vascular Closure Device Collagen Plug-Based MANTA.
    Gheorghe L; Brouwer J; Mathijssen H; Nijenhuis VJ; Rensing BJ; Swaans MJ; Chan Pin Yin DR; Heijmen RH; De Kroon T; Sonker U; Van der Heyden JA; Ten Berg JM
    Am J Cardiol; 2019 Oct; 124(8):1265-1271. PubMed ID: 31443900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How accurate are manufacturers' recommendations in determining ineligibility for transfemoral transcatheter aortic valve implantation?
    Çakal B; Çakal S; Karaca O; Yilmaz FK; Gunes HM; Yıldırım A; Guler Y; Ozcan ÖU; Boztosun B
    Rev Port Cardiol; 2023 Jan; 42(1):31-38. PubMed ID: 36328866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting vascular complications during transfemoral transcatheter aortic valve replacement using computed tomography: a novel area-based index.
    Krishnaswamy A; Parashar A; Agarwal S; Modi DK; Poddar KL; Svensson LG; Roselli EE; Schoenhagen P; Tuzcu EM; Kapadia SR
    Catheter Cardiovasc Interv; 2014 Nov; 84(5):844-51. PubMed ID: 24659145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of Frequency of Vascular Complications With Ultrasound-Guided Versus Fluroscopic Roadmap-Guided Femoral Arterial Access in Patients Who Underwent Transcatheter Aortic Valve Implantation.
    Potluri SP; Hamandi M; Basra SS; Shinn KV; Tabachnick D; Vasudevan A; Filardo G; DiMaio JM; Brinkman WT; Harrington K; Squiers JJ; Szerlip MI; Brown DL; Holper E; Mack MJ
    Am J Cardiol; 2020 Oct; 132():93-99. PubMed ID: 32782067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single versus double use of a suture-based closure device for transfemoral aortic valve implantation.
    Reifart J; Liebetrau C; Weferling M; Dörr O; Renker M; Bhumimuang K; Liakopoulos O; Choi YH; Nef H; Hamm CW; Kim WK
    Int J Cardiol; 2021 May; 331():183-188. PubMed ID: 33529662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of percutaneous femoral arteriotomy closure using the MANTA
    De Palma R; Settergren M; Rück A; Linder R; Saleh N
    Catheter Cardiovasc Interv; 2018 Nov; 92(5):954-961. PubMed ID: 29575678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventral calcification in the common femoral artery: A risk factor for major transcatheter aortic valve intervention access site complications.
    Staudacher DL; Braxmeier K; Stachon P; Hilgendorf I; Schlett C; Zehender M; von Zur Mühlen C; Bode C; Heidt T
    Catheter Cardiovasc Interv; 2021 Nov; 98(6):E947-E953. PubMed ID: 34331732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successfully Managed Access-Site Complication Was Not Associated With Worse Outcome After Percutaneous Transfemoral Transcatheter Aortic Valve Implantation: Up-to-Date Insights From the OCEAN-TAVI Registry.
    Honda Y; Yamawaki M; Nakano T; Makino K; Ito Y; Yashima F; Tada N; Naganuma T; Yamanaka F; Mizutani K; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Shirai S; Hayashida K;
    Cardiovasc Revasc Med; 2022 May; 38():11-18. PubMed ID: 34391679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-year outcomes with two suture-mediated closure devices to achieve access-site haemostasis following transfemoral transcatheter aortic valve implantation.
    Mehilli J; Jochheim D; Abdel-Wahab M; Rizas KD; Theiss H; Spenkuch N; Zadrozny M; Baquet M; El-Mawardy M; Sato T; Lange P; Kuppatt C; Greif M; Hausleiter J; Bauer A; Schwarz F; Pichlmaier M; Hagl C; Richardt G; Massberg S
    EuroIntervention; 2016 Nov; 12(10):1298-1304. PubMed ID: 27866140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of MANTA versus Perclose Prostyle large-bore vascular closure devices during transcatheter aortic valve implantation.
    Barbash IM; Wasserstrum Y; Erlebach M; Guetta V; Ziegelmüller J; Segev A; Fefer P; Maor E; Lange R; Ruge H
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):160-168. PubMed ID: 38059295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfemoral transcatheter aortic valve implantation in patients with small diseased peripheral vessels.
    Ruparelia N; Buzzatti N; Romano V; Longoni M; Figini F; Montorfano M; Kawamoto H; Miyazaki T; Spagnolo P; Alfieri O; Colombo A; Latib A
    Cardiovasc Revasc Med; 2015 Sep; 16(6):326-30. PubMed ID: 26104848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Totally Percutaneous Transfemoral Transcatheter Aortic Valve Replacement Despite Failure to Deploy a Vascular Closure Device: A Single-Centre Case Series.
    Eitan A; Shiran A; Sliman H; Zafrir B; Jaffe R
    Heart Lung Circ; 2022 Mar; 31(3):390-394. PubMed ID: 34607752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Propensity-matched comparison of large-bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real-world experience.
    Medranda GA; Case BC; Zhang C; Rappaport H; Weissman G; Bernardo NL; Satler LF; Ben-Dor I; Rogers T; Waksman R
    Catheter Cardiovasc Interv; 2021 Sep; 98(3):580-585. PubMed ID: 34051039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aortic valve and vascular calcium score in pre-TAVI CT: correlation with early post-procedural complications.
    Milo SM; Toia P; Midiri F; D'Alessandro L; Sollami G; Panci A; Pernice V; Violante F; Fattouch K; Cutaia G; Salvaggio G; Lo Re G; Grassedonio E; Galia M; La Grutta L
    Radiol Med; 2023 Mar; 128(3):299-306. PubMed ID: 36786969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation.
    Costa G; Valvo R; Picci A; Criscione E; Reddavid C; Motta S; Strazzieri O; Deste W; Giuffrida A; Garretto V; Cannizzaro MT; Inserra C; Veroux P; Giaquinta A; Sgroi C; Tamburino C; Barbanti M
    EuroIntervention; 2021 Oct; 17(9):728-735. PubMed ID: 33589411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Obesity and vascular complication in percutaneous transfemoral transcatheter aortic valve insertion.
    Hosseini M; Lahr BD; Greason KL; Arghami A; Gulati R; Eleid MF; Crestanello JA
    Catheter Cardiovasc Interv; 2023 Jun; 101(7):1221-1228. PubMed ID: 37036273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular complications after transcatheter transfemoral aortic valve implantation: Modified sheath-to-femoral artery ratio as a new predictor.
    Çakal S; Çakal B; Karaca O; Güler Y; Özcan ÖU; Güneş HM; Kızılırmak Yılmaz F; Yıldırım A; Boztosun B
    Anatol J Cardiol; 2022 Jan; 26(1):49-56. PubMed ID: 35191386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors and incidence of access site complications in transcatheter aortic valve implantation with the use of new delivery systems.
    Sari C; Ayhan H; Aslan AN; Durmaz T; Keleş T; Baştuğ S; Bayram NA; Bilen E; Kasapkara HA; Bozkurt E
    Perfusion; 2015 Nov; 30(8):666-74. PubMed ID: 25795681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propensity-matched comparison of vascular closure devices after transcatheter aortic valve replacement using MANTA versus ProGlide.
    Moriyama N; Lindström L; Laine M
    EuroIntervention; 2019 Feb; 14(15):e1558-e1565. PubMed ID: 30295293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.